Use of products licensed under scheme can apply where conventional treatments fail. Funding has been made available for a new programme providing cannabis-based medical products to patients to begin later this year, the Department of Health has announced. Use of products licensed under the Medicinal Cannabis Access Programme can apply where conventional treatments are unsuccessful. – Read the entire article at The Irish Times.
